TG Therapeutics | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
AbbVie USD 3.86B 306M 2024-12
Alaunos Therapeutics USD 1.01M 17K 2024-09
Amgen USD 1.88B 253M 2024-12
Ardelyx USD 76.07M 11.1M 2024-12
Arrowhead Research USD 30.2M 1.91M 2024-12
Bayer EUR 4.34B 610M 2024-12
Biogen USD 677.3M 99.6M 2024-12
Corcept Therapeutics USD 83.37M 9.63M 2024-12
Dynavax Technologies USD 41.58M 1.48M 2024-12
Gilead Sciences USD 1.86B 451M 2024-12
J&J USD 6.45B 975M 2024-12
Novartis USD 3.5B 368M 2024-12
PTC Therapeutics USD 84.68M 11.23M 2024-12
Regeneron Pharmaceuticals USD 792.2M 77.8M 2024-12
Roche Holding CHF 3.61B 381M 2024-12
TG Therapeutics USD 38.96M 3M 2024-12
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12



TG Therapeutics Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.